Reply to "Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium"

Affiliations

¹ Department of Molecular Medicine, Scripps Research Institute, Jupiter, Fla. Electronic address: mballow@usf.edu.
² Division of Allergy and Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, St Petersburg, Fla.

Comment

Mark Ballow et al. J Allergy Clin Immunol Pract. 2021 Jun.

. 2021 Jun;9(6):2541-2542.

doi: 10.1016/j.jaip.2021.03.031.

¹ Department of Molecular Medicine, Scripps Research Institute, Jupiter, Fla. Electronic address: mballow@usf.edu.
² Division of Allergy and Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, St Petersburg, Fla.

No abstract available

Comment on

Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium.
Tricarico G, Travagli V. Tricarico G, et al. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2540-2541. doi: 10.1016/j.jaip.2021.02.063. J Allergy Clin Immunol Pract. 2021. PMID: 34112484 Free PMC article. No abstract available.

1. Tricarico G., Travagli V. Patient variability in severity of COVID-19 disease. Main suspect: vascular endothelium. J Allergy Clin Immunol Pract. 2021;9:2540–2541. - PMC - PubMed
1. Ballow M., Haga C.L. Why do some people develop serious COVID-19 disease after infection, while others only exhibit mild symptoms? J Allergy Clin Immunol Pract. 2021;9(4):1442–1448. - PMC - PubMed
1. Hadi H.A.R., Suwaidi J.A. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag. 2007;3:853–876. - PMC - PubMed
1. Konukoglu D., Uzun H. Endothelial dysfunction and hypertension. Adv Exp Med Biol. 2017;956:511–540. - PubMed
1. Avogaro A., de Kreutzenberg S.V. Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta. 2005;360:9–26. - PubMed